scholarly journals Liver transplantation for hepatocellular carcinoma: how far can the selection criteria be expanded?

2012 ◽  
Vol 6 (3) ◽  
pp. 562-563
Author(s):  
Naglaa Allam
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Selection Criteria

Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma

2018 ◽  
Vol 68 (6) ◽  
pp. 1144-1152 ◽  
Author(s):  
Ah Yeong Kim ◽  
Dong Hyun Sinn ◽  
Woo Kyoung Jeong ◽  
Young Kon Kim ◽  
Tae Wook Kang ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Selection Criteria

scholarly journals Liver Transplantation for Extended Criteria Hepatocellular Carcinoma Using Stable Response to Locoregional Therapy and Alpha-Fetoprotein as Selection Criteria

2020 ◽  
Vol 36 (6) ◽  
pp. 506-515
Author(s):  
Markus Bo Schoenberg ◽  
Hubertus Johann Wolfgang Anger ◽  
Julian Nikolaus Bucher ◽  
Gerald Denk ◽  
Enrico Narciso De Toni ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Selection Criteria ◽  
Validation Cohort ◽  
Alpha Fetoprotein ◽  
Long Term Results ◽  
Locoregional Therapy ◽  
Internal Validation ◽  
Dynamic Selection ◽  
Transplant Candidates

<b><i>Introduction:</i></b> Current practice to only prioritize hepatocellular carcinoma (HCC) that fulfill the Milan criteria (IN<sub>MC</sub>) is changing, since it causes the exclusion of patients who could benefit from liver transplantation. To select patients outside MC (OUT<sub>MC</sub>) for transplantation, we implemented extended selection criteria without up-front morphometric restrictions containing surrogate parameters of tumor biology. <b><i>Methods:</i></b> OUT<sub>MC</sub> patients were considered without restrictions of morphometrics and received locoregional treatment after interdisciplinary consultation. Our dynamic selection criteria for OUT<sub>MC</sub> patients required (IN<sub>MUC</sub>): (1) treatment response over (2) at least 6 months and (3) alpha-fetoprotein ≤400 ng/mL over the entire evaluation period. Patients with IN<sub>MC</sub> tumors served as control and internal validation cohort. <b><i>Results:</i></b> 31 of 170 liver transplant candidates were OUT<sub>MC</sub>. Of these, 8 dropped out. The remaining 23 patients met the selection criteria and underwent transplantation. Recurrence-free survival was higher in patients transplanted IN<sub>MC</sub> compared to those OUT<sub>MC</sub> IN<sub>MUC</sub> (92.2% vs. 70.8%; <i>p</i> = 0.026) after 5 years of follow-up. Overall survival showed no significant difference (<i>p</i> = 0.552). With dynamic selection of transplant candidates, recurrence could also be predicted for the IN<sub>MC</sub> patients as internal validation cohort (c-index: 0.896; CI 0.588–0.981, <i>p</i> = 0.005). <b><i>Conclusion:</i></b> Dynamic selection criteria for the stratification of patients with OUT<sub>MC</sub> HCCs is feasible and allows for excellent long-term results and acceptable tumor recurrence rates comparable to IN<sub>MC</sub> patients.

Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma

Surgery ◽  
2013 ◽  
Vol 154 (5) ◽  
pp. 1053-1060 ◽  
Author(s):  
Toshimi Kaido ◽  
Kohei Ogawa ◽  
Akira Mori ◽  
Yasuhiro Fujimoto ◽  
Takashi Ito ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Selection Criteria
Sign in / Sign up

Export Citation Format

Share Document